What is the Price/OCF ratio for Ensysce Biosciences, Inc. (ENSC)?

The Price/OCF ratio for ENSC stock is N/A.

What is the estimated TTM average Price/OCF ratio for Ensysce Biosciences, Inc. (ENSC)?

The estimated TTM average Price/OCF ratio for ENSC stock is 1251.33.

Ensysce Biosciences (ENSC) Price/OCF Ratio: History & Chart

Compare

Ensysce Biosciences, Inc.(ENSC)

Biotechnology · La Jolla, CA

$0.42-0.00 (-0.79%)

Delayed quote: Oct 6, 2026, 12:17 PM EDT

Compare

About Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical firm dedicated to developing novel prescription drugs for the treatment of severe pain in the United States, with a specific focus on preventing opioid addiction, misuse, abuse, and overdose. The company leverages two primary technological frameworks: the Trypsin Activated Abuse Protection (TAAP) platform, which creates opioid prodrugs designed to resist abuse, and the Multi-Pill Abuse Resistance (MPAR) platform, engineered to offer protection against overdose through its advanced opioid prodrug technology. Ensysce's pipeline features several key candidates, including PF614, an oxycodone prodrug developed using the TAAP platform, currently undergoing Phase II clinical trials for both acute and chronic pain management. Another product, PF614-MPAR, is a combination of PF614 and nafamostat, in Phase I clinical development to provide overdose protection against excessive oral consumption. Furthermore, the company is exploring an oral and inhaled formulation of nafamostat for potential use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. The company's development efforts also include PF329, an extended-release hydromorphone prodrug similar to PF614. In the area of ADHD treatment, Ensysce is advancing PF8001 and PF8026, which are extended-release and immediate-release amphetamine prodrugs, respectively, aimed at deterring medication abuse. Additionally, PF26810, an extended-release methadone prodrug, is in development for opioid use disorder. Ensysce Biosciences, Inc. operates from its headquarters in La Jolla, California.

La Jolla, CA

9 employees

www.ensysce.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: D. Lynn Kirkpatrick

View full financials

ENSC Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

PRICE/OCF RATIO AVG TTM

1251.33

PRICE/OCF RATIO AVG 3Y

N/A

PRICE/OCF RATIO AVG 5Y

N/A

PRICE/OCF RATIO AVG 10Y

N/A

PRICE/OCF RATIO AVG 15Y

N/A

PRICE/OCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Ensysce Biosciences, Inc. (ENSC)	$6.39M	N/A	1251.33	N/A	N/A
Femasys Inc. (FEMY)vs ›	$6.31M	N/A	N/A	N/A	N/A
Biomerica, Inc. (BMRA)vs ›	$6.54M	N/A	119.62	119.62	119.62
Enveric Biosciences, Inc. (ENVB)vs ›	$6.62M	N/A	2077.04	2435.48	5326.60
Co-Diagnostics, Inc. (CODX)vs ›	$6.66M	N/A	5.48	12.65	12.65
Scienture Holdings, Inc. (SCNX)vs ›	$6.10M	N/A	N/A	N/A	N/A
Aclarion, Inc. (ACON)vs ›	$6.74M	N/A	N/A	N/A	N/A
Cardio Diagnostics Holdings, Inc. (CDIO)vs ›	$6.02M	N/A	N/A	N/A	N/A
Bolt Biotherapeutics, Inc. (BOLT)vs ›	$6.76M	N/A	N/A	N/A	N/A
Enlivex Therapeutics Ltd. (ENLV)vs ›	$5.91M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

Ensysce Biosciences, Inc. (ENSC)

$6.39M

N/A

1251.33

N/A

Femasys Inc. (FEMY)vs ›

$6.31M

N/A

Biomerica, Inc. (BMRA)vs ›

$6.54M

N/A

119.62

Enveric Biosciences, Inc. (ENVB)vs ›

$6.62M

N/A

2077.04

2435.48

5326.60

Co-Diagnostics, Inc. (CODX)vs ›

$6.66M

N/A

5.48

12.65

Scienture Holdings, Inc. (SCNX)vs ›

$6.10M

N/A

Aclarion, Inc. (ACON)vs ›

$6.74M

N/A

Cardio Diagnostics Holdings, Inc. (CDIO)vs ›

$6.02M

N/A

Bolt Biotherapeutics, Inc. (BOLT)vs ›

$6.76M

N/A

Enlivex Therapeutics Ltd. (ENLV)vs ›

$5.91M

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

DATE	PRICE/OCF RATIO
2021-06-07	2290.02
2021-06-04	1867.64
2021-06-03	2424.02
2021-06-02	2274.75
2021-06-01	2359.57
2021-05-28	2349.39
2021-05-27	2357.87
2021-05-26	2316.31
2021-05-25	2281.53
2021-05-24	2281.53
2021-05-21	2288.32
2021-05-20	2288.32
2021-05-19	2172.97
2021-05-18	2172.97
2021-05-17	2218.77
2021-05-14	2235.73
2021-05-13	2235.73
2021-05-12	2218.77
2021-05-11	2188.24
2021-05-10	2218.77
2021-05-07	2188.24
2021-05-06	2188.24
2021-05-05	2228.95
2021-05-04	2200.06
2021-05-03	2186.54
2021-04-30	2159.40
2021-04-29	2120.39
2021-04-28	2120.39
2021-04-27	2120.37
2021-04-26	2157.70
2021-04-23	2157.70
2021-04-22	2157.69
2021-04-21	2154.14
2021-04-20	2154.21
2021-04-19	2156.01
2021-04-16	2156.01
2021-04-15	2158.21
2021-04-14	2158.21
2021-04-13	2183.15
2021-04-12	2157.33
2021-04-09	2188.92
2021-04-08	2188.87
2021-04-07	2179.76
2021-04-06	2184.85
2021-04-05	2210.27
2021-04-01	2181.45
2021-03-31	2218.75
2021-03-30	2191.61
2021-03-29	2244.23
2021-03-26	2269.66
2021-03-25	2094.19
2021-03-24	2120.37
2021-03-23	2334.12
2021-03-22	2334.10
2021-03-19	2344.30
2021-03-18	2347.69
2021-03-17	2356.17
2021-03-16	2364.65
2021-03-15	32.56
2021-03-12	34.96
2021-03-11	35.11
2021-03-10	34.64
2021-03-09	37.07
2021-03-08	33.68
2021-03-05	38.21
2021-03-04	32.69
2021-03-03	28.50
2021-03-02	33.40
2021-03-01	33.83
2021-02-26	34.89
2021-02-25	32.44
2021-02-24	35.04
2021-02-23	34.07
2021-02-22	36.00
2021-02-19	37.33
2021-02-18	36.10
2021-02-17	36.35
2021-02-16	38.05
2021-02-12	39.52
2021-02-11	40.86
2021-02-10	42.76
2021-02-09	44.20
2021-02-08	44.06
2021-02-05	40.71
2021-02-04	42.47
2021-02-03	44.60
2021-02-02	48.14
2021-02-01	59.41
2021-01-29	30.80
2021-01-28	31.38
2021-01-27	30.31
2021-01-26	31.32
2021-01-25	30.46
2021-01-22	31.60
2021-01-21	31.60
2021-01-20	31.08
2021-01-19	31.35
2021-01-15	30.88
2021-01-14	32.02
2021-01-13	32.19
2021-01-12	31.32
2021-01-11	30.90
2021-01-08	30.90
2021-01-07	29.00
2021-01-06	30.06
2021-01-05	29.49
2021-01-04	30.51
2020-12-31	30.79
2020-12-30	30.55
2020-12-29	31.94
2020-12-28	31.94
2020-12-24	32.87
2020-12-23	32.54
2020-12-22	29.10
2020-12-21	27.85
2020-12-18	27.86
2020-12-17	29.10
2020-12-16	27.98
2020-12-15	28.00
2020-12-14	29.72
2020-12-11	31.70
2020-12-10	28.11
2020-12-09	26.21
2020-12-08	26.21
2020-12-07	26.84
2020-12-04	26.99
2020-12-03	27.24
2020-12-02	28.77
2020-12-01	26.03
2020-11-30	27.69
2020-11-27	26.03
2020-11-25	26.03
2020-11-24	26.00
2020-11-23	26.00
2020-11-20	26.00
2020-11-19	26.00
2020-11-18	26.00
2020-11-17	26.00
2020-11-16	26.00
2020-11-13	25.93
2020-11-12	25.93
2020-11-11	26.00
2020-11-10	25.60
2020-11-09	1690.47
2020-11-06	1690.47
2020-11-05	1690.47
2020-11-04	1690.47
2020-11-03	1690.47
2020-11-02	1690.47
2020-10-30	1743.51
2020-10-29	1690.47
2020-10-28	1690.47
2020-10-27	1690.47
2020-10-26	1690.47
2020-10-23	1730.71
2020-10-22	1730.71
2020-10-21	1730.71
2020-10-20	1690.47
2020-10-19	1692.08
2020-10-16	1690.47
2020-10-15	1690.47
2020-10-14	1690.47
2020-10-13	1689.02
2020-10-12	1689.02
2020-10-09	1689.02
2020-10-08	1688.98
2020-10-07	1700.69
2020-10-06	1684.03
2020-10-05	1684.03
2020-10-02	1737.96
2020-10-01	1694.49
2020-09-30	1722.67
2020-09-29	1722.67
2020-09-28	1698.52
2020-09-25	1682.43
2020-09-24	1719.45
2020-09-23	1719.45
2020-09-22	1742.47
2020-09-21	1732.32
2020-09-18	1704.96
2020-09-17	1715.77
2020-09-16	1687.25
2020-09-15	1687.25
2020-09-14	1687.25
2020-09-11	1685.64
2020-09-10	1677.59
2020-09-09	1723.47
2020-09-08	1693.69
2020-09-04	1713.01
2020-09-03	1713.01
2020-09-02	1737.15
2020-09-01	1690.47
2020-08-31	1684.03
2020-08-28	1682.42
2020-08-27	1717.56
2020-08-26	1690.47
2020-08-25	1682.42
2020-08-24	1682.58
2020-08-21	1684.03
2020-08-20	1677.59
2020-08-19	1677.59
2020-08-18	1682.42
2020-08-17	1682.42
2020-08-14	1677.59
2020-08-13	1687.25
2020-08-12	1687.25
2020-08-11	1687.25
2020-08-10	1677.63
2020-08-07	1611.79
2020-08-06	1614.00
2020-08-05	1615.66
2020-08-04	1648.14
2020-08-03	1613.34
2020-07-31	1613.34
2020-07-30	1633.45
2020-07-29	1633.45
2020-07-28	1633.45
2020-07-27	1707.08
2020-07-24	1624.17
2020-07-23	1625.71
2020-07-22	1639.63
2020-07-21	1641.18
2020-07-20	1639.63
2020-07-17	1678.30
2020-07-16	1686.04
2020-07-15	1647.06
2020-07-14	1633.45
2020-07-13	1617.99
2020-07-10	1637.31
2020-07-09	1619.53
2020-07-08	1614.88
2020-07-07	1633.46
2020-07-06	1663.61
2020-07-02	1672.10
2020-07-01	1715.18
2020-06-30	1811.35
2020-06-29	1701.51
2020-06-26	1616.43
2020-06-25	1616.43
2020-06-24	1607.15
2020-06-23	1817.52
2020-06-22	1832.99
2020-06-19	1935.46
2020-06-18	1991.54
2020-06-17	1854.64
2020-06-16	1613.83
2020-06-15	1611.27
2020-06-12	1617.92
2020-06-11	1631.90
2020-06-10	1639.63
2020-06-09	1701.51
2020-06-08	1661.29
2020-06-05	1699.96
2020-06-04	1715.43
2020-06-03	1711.98
2020-06-02	1717.75
2020-06-01	1686.04
2020-05-29	1686.04
2020-05-28	1608.70
2020-05-27	1608.70

DATE

PRICE/OCF RATIO

2021-06-07

2290.02

2021-06-04

1867.64

2021-06-03

2424.02

2021-06-02

2274.75

2021-06-01

2359.57

2021-05-28

2349.39

2021-05-27

2357.87

2021-05-26

2316.31

2021-05-25

2281.53

2021-05-24

2281.53

2021-05-21

2288.32

2021-05-20

2288.32

2021-05-19

2172.97

2021-05-18

2172.97

2021-05-17

2218.77

2021-05-14

2235.73

2021-05-13

2235.73

2021-05-12

2218.77

2021-05-11

2188.24

2021-05-10

2218.77

2021-05-07

2188.24

2021-05-06

2188.24

2021-05-05

2228.95

2021-05-04

2200.06

2021-05-03

2186.54

2021-04-30

2159.40

2021-04-29

2120.39

2021-04-28

2120.39

2021-04-27

2120.37

2021-04-26

2157.70

2021-04-23

2157.70

2021-04-22

2157.69

2021-04-21

2154.14

2021-04-20

2154.21

2021-04-19

2156.01

2021-04-16

2156.01

2021-04-15

2158.21

2021-04-14

2158.21

2021-04-13

2183.15

2021-04-12

2157.33

2021-04-09

2188.92

2021-04-08

2188.87

2021-04-07

2179.76

2021-04-06

2184.85

2021-04-05

2210.27

2021-04-01

2181.45

2021-03-31

2218.75

2021-03-30

2191.61

2021-03-29

2244.23

2021-03-26

2269.66

2021-03-25

2094.19

2021-03-24

2120.37

2021-03-23

2334.12

2021-03-22

2334.10

2021-03-19

2344.30

2021-03-18

2347.69

2021-03-17

2356.17

2021-03-16

2364.65

2021-03-15

32.56

2021-03-12

34.96

2021-03-11

35.11

2021-03-10

34.64

2021-03-09

37.07

2021-03-08

33.68

2021-03-05

38.21

2021-03-04

32.69

2021-03-03

28.50

2021-03-02

33.40

2021-03-01

33.83

2021-02-26

34.89

2021-02-25

32.44

2021-02-24

35.04

2021-02-23

34.07

2021-02-22

36.00

2021-02-19

37.33

2021-02-18

36.10

2021-02-17

36.35

2021-02-16

38.05

2021-02-12

39.52

2021-02-11

40.86

2021-02-10

42.76

2021-02-09

44.20

2021-02-08

44.06

2021-02-05

40.71

2021-02-04

42.47

2021-02-03

44.60

2021-02-02

48.14

2021-02-01

59.41

2021-01-29

30.80

2021-01-28

31.38

2021-01-27

30.31

2021-01-26

31.32

2021-01-25

30.46

2021-01-22

31.60

2021-01-21

31.60

2021-01-20

31.08

2021-01-19

31.35

2021-01-15

30.88

2021-01-14

32.02

2021-01-13

32.19

2021-01-12

31.32

2021-01-11

30.90

2021-01-08

30.90

2021-01-07

29.00

2021-01-06

30.06

2021-01-05

29.49

2021-01-04

30.51

2020-12-31

30.79

2020-12-30

30.55

2020-12-29

31.94

2020-12-28

31.94

2020-12-24

32.87

2020-12-23

32.54

2020-12-22

29.10

2020-12-21

27.85

2020-12-18

27.86

2020-12-17

29.10

2020-12-16

27.98

2020-12-15

28.00

2020-12-14

29.72

2020-12-11

31.70

2020-12-10

28.11

2020-12-09

26.21

2020-12-08

26.21

2020-12-07

26.84

2020-12-04

26.99

2020-12-03

27.24

2020-12-02

28.77

2020-12-01

26.03

2020-11-30

27.69

2020-11-27

26.03

2020-11-25

26.03

2020-11-24

26.00

2020-11-23

26.00

2020-11-20

26.00

2020-11-19

26.00

2020-11-18

26.00

2020-11-17

26.00

2020-11-16

26.00

2020-11-13

25.93

2020-11-12

25.93

2020-11-11

26.00

2020-11-10

25.60

2020-11-09

1690.47

2020-11-06

1690.47

2020-11-05

1690.47

2020-11-04

1690.47

2020-11-03

1690.47

2020-11-02

1690.47

2020-10-30

1743.51

2020-10-29

1690.47

2020-10-28

1690.47

2020-10-27

1690.47

2020-10-26

1690.47

2020-10-23

1730.71

2020-10-22

1730.71

2020-10-21

1730.71

2020-10-20

1690.47

2020-10-19

1692.08

2020-10-16

1690.47

2020-10-15

1690.47

2020-10-14

1690.47

2020-10-13

1689.02

2020-10-12

1689.02

2020-10-09

1689.02

2020-10-08

1688.98

2020-10-07

1700.69

2020-10-06

1684.03

2020-10-05

1684.03

2020-10-02

1737.96

2020-10-01

1694.49

2020-09-30

1722.67

2020-09-29

1722.67

2020-09-28

1698.52

2020-09-25

1682.43

2020-09-24

1719.45

2020-09-23

1719.45

2020-09-22

1742.47

2020-09-21

1732.32

2020-09-18

1704.96

2020-09-17

1715.77

2020-09-16

1687.25

2020-09-15

1687.25

2020-09-14

1687.25

2020-09-11

1685.64

2020-09-10

1677.59

2020-09-09

1723.47

2020-09-08

1693.69

2020-09-04

1713.01

2020-09-03

1713.01

2020-09-02

1737.15

2020-09-01

1690.47

2020-08-31

1684.03

2020-08-28

1682.42

2020-08-27

1717.56

2020-08-26

1690.47

2020-08-25

1682.42

2020-08-24

1682.58

2020-08-21

1684.03

2020-08-20

1677.59

2020-08-19

1677.59

2020-08-18

1682.42

2020-08-17

1682.42

2020-08-14

1677.59

2020-08-13

1687.25

2020-08-12

1687.25

2020-08-11

1687.25

2020-08-10

1677.63

2020-08-07

1611.79

2020-08-06

1614.00

2020-08-05

1615.66

2020-08-04

1648.14

2020-08-03

1613.34

2020-07-31

1613.34

2020-07-30

1633.45

2020-07-29

1633.45

2020-07-28

1633.45

2020-07-27

1707.08

2020-07-24

1624.17

2020-07-23

1625.71

2020-07-22

1639.63

2020-07-21

1641.18

2020-07-20

1639.63

2020-07-17

1678.30

2020-07-16

1686.04

2020-07-15

1647.06

2020-07-14

1633.45

2020-07-13

1617.99

2020-07-10

1637.31

2020-07-09

1619.53

2020-07-08

1614.88

2020-07-07

1633.46

2020-07-06

1663.61

2020-07-02

1672.10

2020-07-01

1715.18

2020-06-30

1811.35

2020-06-29

1701.51

2020-06-26

1616.43

2020-06-25

1616.43

2020-06-24

1607.15

2020-06-23

1817.52

2020-06-22

1832.99

2020-06-19

1935.46

2020-06-18

1991.54

2020-06-17

1854.64

2020-06-16

1613.83

2020-06-15

1611.27

2020-06-12

1617.92

2020-06-11

1631.90

2020-06-10

1639.63

2020-06-09

1701.51

2020-06-08

1661.29

2020-06-05

1699.96

2020-06-04

1715.43

2020-06-03

1711.98

2020-06-02

1717.75

2020-06-01

1686.04

2020-05-29

1686.04

2020-05-28

1608.70

2020-05-27

1608.70

Price/OCF Ratio: N/A

ENSC Price/OCF Ratio Chart

ENSC Average Price/OCF Ratio Chart

ENSC Price/OCF Ratio Metrics

ENSC Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Price/OCF Ratio FAQ

ENSC Price/OCF Ratio History

Related Metrics